SCHEMBL4350502

SCHEMBL4350502

O=C1N=C(N2CCOCC2)SC1=Cc1ccc(C(=O)O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
ALDH1A1 P00352 7/20 0.61
MAPT P10636 7/20 0.61
KDM4E B2RXH2 1/20 0.61
GAA P10253 1/20 0.61
DCTPP1 Q9H773 1/20 0.60
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
ENPP2 Q13822 1/20 0.58
RAB9A P51151 4/20 0.57
NPC1 O15118 2/20 0.57
SMN1; SMN2 Q16637 3/20 0.56
HCRTR1 O43613 1/20 0.56
NPSR1 Q6W5P4 2/20 0.56
HPGD P15428 1/20 0.56
GRIN1 Q05586 1/20 0.55
GRIN2B Q13224 1/20 0.55
ALOX5 P09917 1/20 0.54
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350500 1.00 MEN1 (0.61) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4346380 0.87 ALDH1A1 (0.60) MEN1KMT2AALDH1A1MAPTDCTPP1
SCHEMBL4346381 0.87 ALDH1A1 (0.60) MEN1KMT2AALDH1A1MAPTDCTPP1
SCHEMBL4352381 0.86 DCTPP1 (0.74) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4352377 0.86 DCTPP1 (0.74) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4356517 0.86 MAPT (0.57) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4352746 0.86 MAPT (0.57) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4354253 0.86 ALDH1A1 (0.78) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4354258 0.86 ALDH1A1 (0.78) MEN1KMT2AALDH1A1MAPTKDM4E
Bromide SCHEMBL4352446 0.85 ALDH1A1 (0.76) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MEN1 1725/4885KMT2A 3923/4885ALDH1A1 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.